Cyberknife Precision Radiation Delivery System for Tumors of the Spine

Trial ID or NCT#

NCT00185666

Status

not recruiting iconNOT RECRUITING

Purpose

The purpose of this study is to determine the usefulness of Cyberknife precision radiation in eliminating or preventing the further growth of spinal tumors and lesions.

Official Title

Cyberknife Precision Radiation Delivery System for Tumors of the Spine

Eligibility Criteria

Ages Eligible for Study: Older than 5 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. - Intra-axial, extra-axial, or vertebral spinal lesion
    1. * Age \> 5* Histologic confirmation of malignant primary lesion or radiographic diagnosis of benign or vascular spinal lesion* No rapidly deteriorating symptoms of spinal cord compression* No instability of the spine* Life expectancy \> 6 months
Exclusion Criteria:
  1. - Patients without tumors of the spine* Patients younger than 5 years old
View All Criteria
Show Less

Investigator(s)

Iris C. Gibbs, MD, FACR, FASTRO
Iris C. Gibbs, MD, FACR, FASTRO
Radiation oncologist, Neuro-oncologist
Professor of Radiation Oncology (Radiation Therapy) and, by courtesy, of Neurosurgery

Contact us to find out if this trial is right for you.

Contact

Laurie Tupper
6507361694

View on ClinicalTrials.gov